NEW
Stock Screener with Intrinsic Value
United Therapeutics Corporation (UTHR)
Last Price$365.0(0.4%)
Market Cap$16.2B
25.0%
Industry median - 13.4%
5Y Historical average - 10.8%
16.3%
Industry median - 1.1%
5Y Historical average - 31.1%
25.9%
Industry median - (20.2%)
5Y Historical average - 23.7%
17.5%
Industry median - (1.2%)
5Y Historical average - 9.2%
UTHR Growth Rating
Crunching data... Almost there!
UTHR Growth Metrics
Crunching data... Almost there!
Competing with UTHR Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the United Therapeutics Corporation (UTHR) revenue growth?
The United Therapeutics Corporation (UTHR) revenue growth is 25.0%, which is lower than the industry median of 13.4% and the 5-year historical average of 10.8%.
What is the United Therapeutics Corporation (UTHR) operating income growth?
The United Therapeutics Corporation (UTHR) operating income growth is 16.3%, compared to the industry median of 1.1% and the 5-year historical average of 31.1%.
What is the United Therapeutics Corporation (UTHR) EPS (Earnings Per Share) growth?
The United Therapeutics Corporation (UTHR) EPS growth is 25.9%, compared to the industry median of (20.2%) and the 5-year historical average of 23.7%.
What is the United Therapeutics Corporation (UTHR) Free Cash Flow (FCF) growth?
The United Therapeutics Corporation (UTHR) Free Cash Flow growth is 17.5%, compared to the industry median of (1.2%) and the 5-year historical average of 9.2%.